You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Acetaminophen, Caffeine And Dihydrocodeine Bitartrate, and when can generic versions of Acetaminophen, Caffeine And Dihydrocodeine Bitartrate launch?

Acetaminophen, Caffeine And Dihydrocodeine Bitartrate is a drug marketed by Larken Labs Inc and is included in one NDA.

The generic ingredient in ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
  • What are the global sales for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
  • What is Average Wholesale Price for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE?
Summary for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE at DailyMed
Drug patent expirations by year for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE

US Patents and Regulatory Information for ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Larken Labs Inc ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE acetaminophen; caffeine; dihydrocodeine bitartrate TABLET;ORAL 204209-001 Sep 30, 2016 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.